Objectives Studies assessing relative mortality risks across the spectrum of systemic
inflammatory rheumatic diseases are largely missing. In this study, we wanted to estimate …

Objectives To explore mortality and causes of death among Norwegian patients with RA,
PsA and axial spondyloarthritis (axSpA) compared with the general population by …

Background Musculoskeletal (MSK) diseases are expected to have a growing impact
worldwide. Objective To analyse the worldwide burden of MSK diseases from 2000 to 2015 …

Introduction The public–private ADVANCE collaboration developed and tested a system to
generate evidence on vaccine benefits and risks using European electronic healthcare …

Background Current studies on musculoskeletal (MSK) disorders mainly focus on the
elderly, while adolescents and young adults (AYAs) are often neglected despite their unique …

Approximately 5% of the world-wide population is affected by autoimmune diseases.
Overall, autoimmune diseases are still difficult to treat, impose a high burden on patients …

Systemic autoimmune diseases (SADs) are a significant cause of morbidity and mortality
worldwide, although their epidemiological profile varies significantly country by country. We …

Background Survival in systemic lupus erythematosus (SLE) has improved substantially in
the last 50 years. The aim of the present study was to assess the evolution of the all-cause …

Background Some autoimmune diseases are associated with an increased risk of
cardiovascular disease. We aimed to determine whether or not this is true, and to what …

Objective To determine trends in survival among adult and paediatric patients with systemic
lupus erythematosus (SLE) from 1950 to the present. Methods We performed a systematic …